Search

everythinglearnresearchcommunity

for

Search:↓

Some treatments for hereditary hair loss are effective but vary in results and side effects; new therapies show promise but need more research.

Oxidative stress and mitophagy play key roles in hair loss, suggesting potential treatment targets.

Thermus thermophilus extract improves hair growth and scalp health in men with hair loss.

Certain genetic variants and pathways are linked to hair loss.

PCOS may increase the risk of mental health issues like depression and anxiety.

Some lesser-known causes of PCOS include autoimmune issues, genetic mutations, and changes in the body's microbiome.

Androgenetic alopecia causes hair thinning due to increased androgen activity, treatable with minoxidil and finasteride.

Finasteride-loaded microemulsions, made with cinnamon oil, Tween20, propylene glycol, and water, can help maintain stemness of dermal cells, potentially aiding in hair regeneration.

Gut bacteria imbalance may cause Post-Finasteride Syndrome symptoms.

Gut bacteria imbalance may cause Post-Finasteride Syndrome symptoms.

Prostate cancer can progress even with low testosterone due to internal hormone production in the tumor.

Women with Polycystic Ovary Syndrome (PCOS) have a higher risk of developing type 2 diabetes due to insulin resistance.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Bolandiol, a synthetic steroid, builds muscle and bone without greatly affecting sex glands, and works differently from other hormones.

Limosilactobacillus reuteri from honeybees may promote hair growth by activating a specific cell pathway.

Androgenetic alopecia treatments focus on reducing hair loss by targeting hormones, with new therapies showing promise but needing more research.

Amygdalin in Persicae Semen may help treat hair loss by promoting hair growth and regulating key pathways.

Blocking the protein CXCL12 with a specific antibody can increase hair growth in common hair loss conditions.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

New treatment with Wnt proteins and growth factors safely increases hair thickness.

Connarus semidecandrus Jack extract promotes hair growth and thickness, reduces prostate cancer cell growth, and could potentially be used as a treatment for hair loss.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

Necrosulfonamide helps hair grow by blocking a protein linked to hair loss.

Exercise, especially vigorous aerobic and resistance training, can improve hormone levels in women with PCOS.

Wedelolactone selectively kills prostate cancer cells without harming normal cells.

Mutations in the NR3C1 gene cause a rare condition that affects hormone signaling and can lead to various symptoms, with dexamethasone as a treatment option.

Androgens may influence bladder cancer progression by affecting cellular behavior.